Department of Chemistry, University of Waterloo, Waterloo, Canada.
Anal Chim Acta. 2012 Sep 12;742:37-44. doi: 10.1016/j.aca.2012.01.034. Epub 2012 Jan 28.
In vivo solid-phase microextraction (SPME) can be used to sample the circulating blood of animals without the need to withdraw a representative blood sample. In this study, in vivo SPME in combination with liquid-chromatography tandem mass spectrometry (LC-MS/MS) was used to determine the pharmacokinetics of two drug analytes, R,R-fenoterol and R,R-methoxyfenoterol, administered as 5 mg kg(-1) i.v. bolus doses to groups of 5 rats. This research illustrates, for the first time, the feasibility of the diffusion-based calibration interface model for in vivo SPME studies. To provide a constant sampling rate as required for the diffusion-based interface model, partial automation of the SPME sampling of the analytes from the circulating blood was accomplished using an automated blood sampling system. The use of the blood sampling system allowed automation of all SPME sampling steps in vivo, except for the insertion and removal of the SPME probe from the sampling interface. The results from in vivo SPME were compared to the conventional method based on blood withdrawal and sample clean up by plasma protein precipitation. Both whole blood and plasma concentrations were determined by the conventional method. The concentrations of methoxyfenoterol and fenoterol obtained by SPME generally concur with the whole blood concentrations determined by the conventional method indicating the utility of the proposed method. The proposed diffusion-based interface model has several advantages over other kinetic calibration models for in vivo SPME sampling including (i) it does not require the addition of a standard into the sample matrix during in vivo studies, (ii) it is simple and rapid and eliminates the need to pre-load appropriate standard onto the SPME extraction phase and (iii) the calibration constant for SPME can be calculated based on the diffusion coefficient, extraction time, fiber length and radius, and size of the boundary layer. In the current study, the experimental calibration constants of 338.9±30 mm(-3) and 298.5±25 mm(-3) are in excellent agreement with the theoretical calibration constants of 307.9 mm(-3) and 316.0 mm(-3) for fenoterol and methoxyfenoterol respectively.
体内固相微萃取 (SPME) 可用于采样动物的循环血液,而无需抽取有代表性的血样。在这项研究中,将体内 SPME 与液相色谱串联质谱 (LC-MS/MS) 相结合,用于测定以 5mgkg(-1)静脉推注剂量给予 5 只大鼠的两种药物分析物 R,R-芬特罗和 R,R-甲氧基芬特罗的药代动力学。本研究首次说明了扩散型校准界面模型在体内 SPME 研究中的可行性。为了为扩散型界面模型提供所需的恒定采样率,使用自动采血系统对循环血液中的分析物进行体内 SPME 采样的部分自动化。使用采血系统可以实现除从采样界面插入和移除 SPME 探头之外的所有体内 SPME 采样步骤的自动化。体内 SPME 的结果与基于采血和通过血浆蛋白沉淀进行样品净化的常规方法进行了比较。通过常规方法确定全血和血浆浓度。通过 SPME 获得的甲氧基芬特罗和芬特罗浓度通常与常规方法确定的全血浓度一致,表明该方法的实用性。与其他体内 SPME 采样的动力学校准模型相比,所提出的基于扩散的界面模型具有几个优势,包括:(i) 它不需要在体内研究期间向样品基质中添加标准;(ii) 它简单快速,消除了在 SPME 萃取阶段上预加载适当标准的需要;(iii) 基于扩散系数、萃取时间、纤维长度和半径以及边界层尺寸,可以计算 SPME 的校准常数。在当前研究中,实验校准常数 338.9±30mm(-3)和 298.5±25mm(-3)与芬特罗和甲氧基芬特罗的理论校准常数 307.9mm(-3)和 316.0mm(-3)非常吻合。